SymBio Pharmaceuticals
Verified Launch date
Employees
Market cap
JPY7.7b
Net debt
JPY6.6b
Enterprise valuation
$9m (Public information from Jun 2024)
Share price
JPY181 4582.T
Durham North Carolina (HQ)
| JPY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 5 % | 176 % | 21 % | (44 %) | (70 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (150 %) | (166 %) | 13 % | 20 % | (4 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (154 %) | (137 %) | 25 % | 12 % | (35 %) | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
JPY3.0b | Post IPO Debt | ||
| Total Funding | 000k | ||
Recent News about SymBio Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.